Robert A. Byrne

52.5k total citations · 7 hit papers
332 papers, 12.9k citations indexed

About

Robert A. Byrne is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robert A. Byrne has authored 332 papers receiving a total of 12.9k indexed citations (citations by other indexed papers that have themselves been cited), including 221 papers in Surgery, 202 papers in Cardiology and Cardiovascular Medicine and 85 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robert A. Byrne's work include Coronary Interventions and Diagnostics (207 papers), Antiplatelet Therapy and Cardiovascular Diseases (85 papers) and Cardiac Imaging and Diagnostics (84 papers). Robert A. Byrne is often cited by papers focused on Coronary Interventions and Diagnostics (207 papers), Antiplatelet Therapy and Cardiovascular Diseases (85 papers) and Cardiac Imaging and Diagnostics (84 papers). Robert A. Byrne collaborates with scholars based in Germany, Ireland and United States. Robert A. Byrne's co-authors include Adnan Kastrati, Albert Schömig, Julinda Mehilli, S. Schulz, Massimiliano Fusaro, Michael Joner, Karl‐Ludwig Laugwitz, Steffen Maßberg, Salvatore Cassese and Melchior Seyfarth and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Robert A. Byrne

312 papers receiving 12.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized Clinical Trial to Evaluate the Safety and Efficacy of a Percutaneous Left Ventricular Assist Device Versus Intra-Aortic Balloon Pumping for Treatment of Cardiogenic Shock Caused by Myocardial Infarction

2008 689 citations Robert A. Byrne, Adnan Kastrati et al. profile →
Current Treatment of In-Stent Restenosis

2014 388 citations Fernándo Alfonso, Robert A. Byrne et al. profile →
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014

2015 379 citations Robert A. Byrne, Adnan Kastrati et al. European Heart Journal profile →
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

2017 337 citations Davide Capodanno, Julinda Mehilli et al. European Heart Journal profile →
Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment

2015 327 citations Robert A. Byrne, Erion Xhepa et al. European Heart Journal profile →
Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

2012 313 citations Robert A. Byrne, Franz–Josef Neumann et al. profile →
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

2015 287 citations Julinda Mehilli, Stefanie Schüpke et al. profile →

Peers

Countries citing papers authored by Robert A. Byrne

Since Specialization

Citations

This map shows the geographic impact of Robert A. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Byrne more than expected).

Fields of papers citing papers by Robert A. Byrne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Byrne. The network helps show where Robert A. Byrne may publish in the future.

Co-authorship network of co-authors of Robert A. Byrne

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Byrne. A scholar is included among the top collaborators of Robert A. Byrne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Byrne. Robert A. Byrne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union	European Heart Journal - Quality of Care and Clinical Outcomes	J J Coughlan, Robert A. Byrne et al.	0
2	Pre‐Percutaneous Coronary Intervention C‐Reactive Protein Levels and In‐Stent Restenosis: A Systematic Review and Meta‐Analysis	Health Science Reports	Himanshu Rai, J J Coughlan et al.	0
3	How common is secondary psychosis? Estimates from a systematic review and meta‐analysis	World Psychiatry	Graham Blackman, Robert A. Byrne et al.	3
4	Tiempos para la revascularización multivaso en pacientes estables con IAMCEST: revisión sistemática y metanálisis en red	Revista Española de Cardiología	Thorsten Kessler, Sebastian Kufner et al.	0
5	A Prospective, Randomized Trial of Bioresorbable Polymer Drug-Eluting Stents versus Fully Bioresorbable Scaffolds in Patients Undergoing Coronary Stenting	Journal of Clinical Medicine	Jens Wiebe, Robert A. Byrne et al.	1
6	Trade-offs between vessel-based and substrate-based nomenclatures for coronary heart diseases	Nature Reviews Cardiology	Robert A. Byrne, Adnan Kastrati	1
7	The ‘10 commandments’ for the 2023 ESC Guidelines for the management of acute coronary syndromes	European Heart Journal	Robert A. Byrne, J J Coughlan et al.	29
8	Left Ventricular Ejection Fraction Change Following Percutaneous Coronary Intervention: Correlates and Association With Prognosis	Journal of the American Heart Association	Gjin Ndrepepa, Salvatore Cassese et al.	2
9	Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium	European Heart Journal	George C.M. Siontis, Bernadette Coles et al.	14
10	2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG	European Heart Journal	Robert A. Byrne, Stephen E. Fremes et al.	25
11	2022 Joint ESC/EACTS review of the 2018 guideline recommendations on the revascularization of left main coronary artery disease in patients at low surgical risk and anatomy suitable for PCI or CABG	European Journal of Cardio-Thoracic Surgery	Robert A. Byrne, Stephen E. Fremes et al.	24
12	Fractional flow reserve or 3D-quantitative-coronary-angiography based vessel-FFR guided revascularization. Rationale and study design of the prospective randomized fast III trial	American Heart Journal	Alessandra Scoccia, Robert A. Byrne et al.	9
13	Stent Optimization Using Optical Coherence Tomography and Its Prognostic Implications After Percutaneous Coronary Intervention	Journal of the American Heart Association	Himanshu Rai, Tatsuhiko Otsuka et al.	8
14	Transforming Access to Clean Energy Technologies in the Global South: Learning from Lighting Africa in Kenya	Energies	David Ockwell, Robert A. Byrne et al.	12
15	Optical Coherence Tomography Assessment in Patients Treated With Rotational Atherectomy Versus Modified Balloons	Circulation Cardiovascular Interventions	Rayyan Hemetsberger, Tommaso Gori et al.	24
16	Markers of Reperfusion and Long-Term (8-Year) Prognosis after Primary Percutaneous Coronary Intervention	The American Journal of Cardiology	Gjin Ndrepepa, Robert A. Byrne et al.	4
17	Comparative efficacy of two paclitaxel-coated balloons with different excipient coatings in patients with coronary in-stent restenosis	International Journal of Cardiology	Róisín Colleran, Michael Joner et al.	18
18	Long-Term Efficacy and Safety of Paclitaxel-Eluting Balloon for the Treatment of Drug-Eluting Stent Restenosis	JACC: Cardiovascular Interventions	Sebastian Kufner, Salvatore Cassese et al.	78
19	Financing sustainable energy for all: pay-as-you-go vs. traditional solar finance approaches in Kenya	Sussex Research Online (University of Sussex)	Robert A. Byrne, David Ockwell et al.	14
20	Prognostic value of late gadolinium enhancement in cardiovascular magnetic resonance imaging after acute ST-elevation myocardial infarction in comparison with single-photon emission tomography using Tc99m-Sestamibi	European Heart Journal - Cardiovascular Imaging	Martin Hadamitzky, Bettina Langhans et al.	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact